Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease

Non-alcoholic fatty liver is the most common liver disease worldwide. Here, we show that the mitochondrial protein mitofusin 2 (Mfn2) protects against liver disease. Reduced Mfn2 expression was detected in liver biopsies from patients with non-alcoholic steatohepatitis (NASH). Moreover, reduced Mfn2...

Descripción completa

Detalles Bibliográficos
Autores: Hernández-Alvarez, María Isabel, Sebastián, David, Vives, Sara, Ivanova, Sa ka, Bartoccioni, Paola, Kakimoto, Pamela, Plana, Natalia, Veiga, Sónia R., Hernández, Vanessa, Vasconcelos, Nuno, Gopalacharyulu, Peddinti, Adrover, Anna, Jové Font, Mariona, Pamplona Gras, Reinald, Berenguer-Llergo, Antonio, Gordaliza, Isabel, Calvo, Enrique, Cabré, Noemí, Castro, Rui, Kuzmanic, Antonija, Boutant, Marie, Sala, David, Hyotylainen, Tuulia, Oresic, Matej, Fort, Joana, Errasti-Murugarren, Ekaitz, Orozco, Modesto, Joven, Jorge, Cantó, Carles, Palacin, Manuel, Fernández-Veledo, Sonia, Vendrell, Joan, Zorzano, Antonio
Tipo de recurso: artículo
Estado:Versión enviada para evaluación y publicación
Fecha de publicación:2019
País:España
Institución:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
Repositorio:Recercat. Dipósit de la Recerca de Catalunya
OAI Identifier:oai:recercat.cat:10459.1/70932
Acceso en línea:https://doi.org/10.1016/j.cell.2019.04.010
http://hdl.handle.net/10459.1/70932
Access Level:acceso abierto
Palabra clave:Mfn2
NASH
Phosphatidylserine
MAMs
Mitochondria
Phospholipid transfer
id ES_8f5b85fced077e54311a5ea2e7d74499
oai_identifier_str oai:recercat.cat:10459.1/70932
network_acronym_str ES
network_name_str España
repository_id_str
spelling Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver diseaseHernández-Alvarez, María IsabelSebastián, DavidVives, SaraIvanova, Sa kaBartoccioni, PaolaKakimoto, PamelaPlana, NataliaVeiga, Sónia R.Hernández, VanessaVasconcelos, NunoGopalacharyulu, PeddintiAdrover, AnnaJové Font, MarionaPamplona Gras, ReinaldBerenguer-Llergo, AntonioGordaliza, IsabelCalvo, EnriqueCabré, NoemíCastro, RuiKuzmanic, AntonijaBoutant, MarieSala, DavidHyotylainen, TuuliaOresic, MatejFort, JoanaErrasti-Murugarren, EkaitzOrozco, ModestoJoven, JorgeCantó, CarlesPalacin, ManuelFernández-Veledo, SoniaVendrell, JoanZorzano, AntonioMfn2NASHPhosphatidylserineMAMsMitochondriaPhospholipid transferNon-alcoholic fatty liver is the most common liver disease worldwide. Here, we show that the mitochondrial protein mitofusin 2 (Mfn2) protects against liver disease. Reduced Mfn2 expression was detected in liver biopsies from patients with non-alcoholic steatohepatitis (NASH). Moreover, reduced Mfn2 levels were detected in mouse models of steatosis or NASH, and its re-expression in a NASH mouse model ameliorated the disease. Liver-specific ablation of Mfn2 in mice provoked inflammation, triglyceride accumulation, fibrosis, and liver cancer. We demonstrate that Mfn2 binds phosphatidylserine (PS) and can specifically extract PS into membrane domains, favoring PS transfer to mitochondria and mitochondrial phosphatidylethanolamine (PE) synthesis. Consequently, hepatic Mfn2 deficiency reduces PS transfer and phospholipid synthesis, leading to endoplasmic reticulum (ER) stress and the development of a NASH-like phenotype and liver cancer. Ablation of Mfn2 in liver reveals that disruption of ER-mitochondrial PS transfer is a new mechanism involved in the development of liver disease.This study was supported by the MINECO (SAF2016-75246R), the Generalitat de Catalunya (2014SGR48, 2017SGR696, ICREA Acadèmia), INFLAMES (PIE-14/00045, ISCIII), CIBERDEM, ISCIII, INTERREG IV-B-SUDOE-FEDER (DIOMED, SOE1/P1/E178), and “la Caixa” Foundation. S.F.-V. acknowledges support from the Miguel Servet tenure-track program (CP10/00438 and CPII16/00008) from the Fondo de Investigación Sanitaria, co-financed by the ERD. We gratefully acknowledge institutional funding from the MINECO through the Centres of Excellence Severo Ochoa Award and from the CERCA Programme of the Generalitat de Catalunya.Elsevier2021202120192021info:eu-repo/semantics/articleinfo:eu-repo/semantics/submittedVersionapplication/pdfhttps://doi.org/10.1016/j.cell.2019.04.010http://hdl.handle.net/10459.1/70932http://hdl.handle.net/10459.1/70932reponame:Recercat. Dipósit de la Recerca de Catalunyainstname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)Inglésinfo:eu-repo/grantAgreement/MINECO//SAF2016-75246-RVersió preprint del document publicat a: https://doi.org/10.1016/j.cell.2019.04.010Cell, 2019, vol. 177, núm. 4, p. 881-895(c) Elsevier, 2019info:eu-repo/semantics/openAccessoai:recercat.cat:10459.1/709322026-05-29T05:05:01Z
dc.title.none.fl_str_mv Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
title Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
spellingShingle Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
Hernández-Alvarez, María Isabel
Mfn2
NASH
Phosphatidylserine
MAMs
Mitochondria
Phospholipid transfer
title_short Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
title_full Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
title_fullStr Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
title_full_unstemmed Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
title_sort Deficient endoplasmic reticulum-mitochondrial phosphatidylserine transfer causes liver disease
dc.creator.none.fl_str_mv Hernández-Alvarez, María Isabel
Sebastián, David
Vives, Sara
Ivanova, Sa ka
Bartoccioni, Paola
Kakimoto, Pamela
Plana, Natalia
Veiga, Sónia R.
Hernández, Vanessa
Vasconcelos, Nuno
Gopalacharyulu, Peddinti
Adrover, Anna
Jové Font, Mariona
Pamplona Gras, Reinald
Berenguer-Llergo, Antonio
Gordaliza, Isabel
Calvo, Enrique
Cabré, Noemí
Castro, Rui
Kuzmanic, Antonija
Boutant, Marie
Sala, David
Hyotylainen, Tuulia
Oresic, Matej
Fort, Joana
Errasti-Murugarren, Ekaitz
Orozco, Modesto
Joven, Jorge
Cantó, Carles
Palacin, Manuel
Fernández-Veledo, Sonia
Vendrell, Joan
Zorzano, Antonio
author Hernández-Alvarez, María Isabel
author_facet Hernández-Alvarez, María Isabel
Sebastián, David
Vives, Sara
Ivanova, Sa ka
Bartoccioni, Paola
Kakimoto, Pamela
Plana, Natalia
Veiga, Sónia R.
Hernández, Vanessa
Vasconcelos, Nuno
Gopalacharyulu, Peddinti
Adrover, Anna
Jové Font, Mariona
Pamplona Gras, Reinald
Berenguer-Llergo, Antonio
Gordaliza, Isabel
Calvo, Enrique
Cabré, Noemí
Castro, Rui
Kuzmanic, Antonija
Boutant, Marie
Sala, David
Hyotylainen, Tuulia
Oresic, Matej
Fort, Joana
Errasti-Murugarren, Ekaitz
Orozco, Modesto
Joven, Jorge
Cantó, Carles
Palacin, Manuel
Fernández-Veledo, Sonia
Vendrell, Joan
Zorzano, Antonio
author_role author
author2 Sebastián, David
Vives, Sara
Ivanova, Sa ka
Bartoccioni, Paola
Kakimoto, Pamela
Plana, Natalia
Veiga, Sónia R.
Hernández, Vanessa
Vasconcelos, Nuno
Gopalacharyulu, Peddinti
Adrover, Anna
Jové Font, Mariona
Pamplona Gras, Reinald
Berenguer-Llergo, Antonio
Gordaliza, Isabel
Calvo, Enrique
Cabré, Noemí
Castro, Rui
Kuzmanic, Antonija
Boutant, Marie
Sala, David
Hyotylainen, Tuulia
Oresic, Matej
Fort, Joana
Errasti-Murugarren, Ekaitz
Orozco, Modesto
Joven, Jorge
Cantó, Carles
Palacin, Manuel
Fernández-Veledo, Sonia
Vendrell, Joan
Zorzano, Antonio
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv Mfn2
NASH
Phosphatidylserine
MAMs
Mitochondria
Phospholipid transfer
topic Mfn2
NASH
Phosphatidylserine
MAMs
Mitochondria
Phospholipid transfer
description Non-alcoholic fatty liver is the most common liver disease worldwide. Here, we show that the mitochondrial protein mitofusin 2 (Mfn2) protects against liver disease. Reduced Mfn2 expression was detected in liver biopsies from patients with non-alcoholic steatohepatitis (NASH). Moreover, reduced Mfn2 levels were detected in mouse models of steatosis or NASH, and its re-expression in a NASH mouse model ameliorated the disease. Liver-specific ablation of Mfn2 in mice provoked inflammation, triglyceride accumulation, fibrosis, and liver cancer. We demonstrate that Mfn2 binds phosphatidylserine (PS) and can specifically extract PS into membrane domains, favoring PS transfer to mitochondria and mitochondrial phosphatidylethanolamine (PE) synthesis. Consequently, hepatic Mfn2 deficiency reduces PS transfer and phospholipid synthesis, leading to endoplasmic reticulum (ER) stress and the development of a NASH-like phenotype and liver cancer. Ablation of Mfn2 in liver reveals that disruption of ER-mitochondrial PS transfer is a new mechanism involved in the development of liver disease.
publishDate 2019
dc.date.none.fl_str_mv 2019
2021
2021
2021
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/submittedVersion
format article
status_str submittedVersion
dc.identifier.none.fl_str_mv https://doi.org/10.1016/j.cell.2019.04.010
http://hdl.handle.net/10459.1/70932
http://hdl.handle.net/10459.1/70932
url https://doi.org/10.1016/j.cell.2019.04.010
http://hdl.handle.net/10459.1/70932
dc.language.none.fl_str_mv Inglés
language_invalid_str_mv Inglés
dc.relation.none.fl_str_mv info:eu-repo/grantAgreement/MINECO//SAF2016-75246-R
Versió preprint del document publicat a: https://doi.org/10.1016/j.cell.2019.04.010
Cell, 2019, vol. 177, núm. 4, p. 881-895
dc.rights.none.fl_str_mv (c) Elsevier, 2019
info:eu-repo/semantics/openAccess
rights_invalid_str_mv (c) Elsevier, 2019
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.publisher.none.fl_str_mv Elsevier
publisher.none.fl_str_mv Elsevier
dc.source.none.fl_str_mv reponame:Recercat. Dipósit de la Recerca de Catalunya
instname:Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
instname_str Varias* (Consorci de Biblioteques Universitáries de Catalunya, Centre de Serveis Científics i Acadèmics de Catalunya)
reponame_str Recercat. Dipósit de la Recerca de Catalunya
collection Recercat. Dipósit de la Recerca de Catalunya
repository.name.fl_str_mv
repository.mail.fl_str_mv
_version_ 1869413205250408448
score 15.811543